To further examine the finding that LEP promoter hypermethylation is associated with poor prognosis in MDS, we included data from an unpublished project where methylation in bone marrow MNCs was evaluated using EPIC BeadChip microarray in 55 MDS patients comprising the validation cohort (Fig. 1). Here, LEP is linked to myelodysplastic syndrome.